VEGF-A Splice Variants and Related Receptor Expression in Human Skeletal Muscle Following Submaximal Exercise
Overview
Affiliations
VEGF-A contributes to muscle tissue angiogenesis following aerobic exercise training. The temporal response of the VEGF-A isoforms and their target receptors has not been comprehensively profiled in human skeletal muscle. We combined submaximal exercise with and without reduced leg blood flow to establish whether ischemia-induced metabolic stress was an important physiological stimuli responsible for regulating the VEGF-A system in humans. Nine healthy men performed two 45-min bouts of one-leg knee-extension exercise, with and without blood flow restriction. Muscle biopsies were obtained at rest and 2 and 6 h after exercise. Expression (mRNA) of the VEGF-A splice variants and related receptors [VEGF receptor (VEGFR)-1, VEGFR-2, and neuropilin-1] was determined by using qPCR. VEGF-A(total) expression increased more robustly after exercise with reduced blood flow, and initially this principally reflected an increase in VEGF-A(165). Six hours after exercise, there was a relatively greater increase in VEGF-A(189), and this response was not influenced by blood flow conditions. VEGFR-1 mRNA expression increased 2 h after exercise, and neuropilin-1 expression was transiently reduced, while all three receptors increased by 6 h. There was no evidence for the expression of the inhibitory VEGF-A(165B) variant in human skeletal muscle. Our study, reflecting both VEGF-A ligand and receptors, implicates metabolic perturbation as a regulator of human muscle angiogenesis and demonstrates that VEGF-A splice variants are distinctly regulated. Our findings also indicate that all three receptor genes exhibit different pretranslational regulation, in response to exercise in humans.
Breese B, Bailey S, Ferguson R Eur J Appl Physiol. 2024; 125(3):851-868.
PMID: 39438313 DOI: 10.1007/s00421-024-05645-6.
Kargl C, Jia Z, Shera D, Sullivan B, Burton L, Kim K Sci Rep. 2023; 13(1):18943.
PMID: 37919323 PMC: 10622454. DOI: 10.1038/s41598-023-45787-9.
Maga M, Wachsmann-Maga A, Batko K, Wlodarczyk A, Klapacz P, Krezel J Biomedicines. 2023; 11(6).
PMID: 37371696 PMC: 10295844. DOI: 10.3390/biomedicines11061601.
Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq.
Stokes T, Cen H, Kapranov P, Gallagher I, Pitsillides A, Volmar C Adv Genet (Hoboken). 2023; 4(2):2200024.
PMID: 37288167 PMC: 10242409. DOI: 10.1002/ggn2.202200024.
Abrishami Kia Z, Sadati Bizaki S, Asaadi Ghareh Tapeh E, Harijani S, Katal N, Gorji Baziary R Toxicol Rep. 2022; 9:1452-1460.
PMID: 36518398 PMC: 9742915. DOI: 10.1016/j.toxrep.2022.06.018.